journal article·2024-05-13Open access

Use of Local Melatonin with Xenogeneic Bone Graft to Treat Critical-Size Bone Defects in Rats with Osteoporosis: A Randomized Study

Karen Laurene Dalla Costa, Letícia Furtado Abreu, Camila Barreto Tolomei, Rachel Gomes Eleutério, Rosanna Basting, Gabriela Balbinot, Fabrício Mezzomo Collares, Pedro Lopes, Nelio Veiga, Gustavo Vicentis Oliveira Fernandes, Daiane Cristina Peruzzo

Abstract

The aim of this study was to evaluate the effect of local administration of melatonin (MLT) on molecular biomarkers and calvaria bone critical defects in female rats with or without osteoporosis, associated or not with a xenogeneic biomaterial. Forty-eight female rats were randomly divided into two groups: (O) ovariectomized and (S) placebo groups. After 45 days of osteoporosis induction, two critical-size defects (5 mm diameter) were created on the calvaria. The groups were subdivided according to the following treatment: (C) Clot, MLT, MLT associated with Bio-Oss® (MLTBO), and Bio-Oss® (BO). After 45 days, the defect samples were collected and processed for microtomography, histomorphometry, and biomolecular analysis (Col-I, BMP-2, and OPN). All animals had one femur harvested to confirm the osteoporosis. Microtomography analysis demonstrated a bone mineral density reduction in the O group. Regarding bone healing, the S group presented greater filling of the defects than the O group; however, in the O group, the defects treated with MLT showed higher mineral filling than the other treatments. There was no difference between the treatments performed in the S group (p = 0.05). Otherwise, O-MLT had neoformed bone higher than in the other groups (p = 0.05). The groups that did not receive biomaterial demonstrated lower levels of Col-I secretion; S-MLT and S-MLTBO presented higher levels of OPN, while O-C presented statistically lower results (p < 0.05); O-BO showed greater BMP-2 secretion (p < 0.05). In the presence of ovariectomy-induced osteoporosis, MLT treatment increased the newly formed bone area, regulated the inflammatory response, and increased OPN expression.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone health and osteoporosis research · Spaceflight effects on biology · Birth, Development, and Health

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Periodontics, São Leopoldo Mandic Research Institute, Campinas 13045-755, SP, Brazil

Laboratory of Dental Materials, Faculty of Dentistry of the Federal University of Rio Grande do Sul (UFRGS), Porto Alegre 90035-004, RS, Brazil

Faculty of Dental Medicine, Universidade Católica Portuguesa, 3504-505 Viseu, Portugal

Centre for Interdisciplinary Research in Health (CIIS), Faculty of Dental Medicine, Universidade Católica Portuguesa, 3504-505 Viseu, Portugal

Missouri School of Dentistry & Oral Health, A. T. Still University, St. Louis, MO 63104, USA

Funding

FCT—Fundação para a Ciência e a Tecnologia

References (46)

Show source-provided references
1. Bone remodeling: An operational process ensuring survival and bone mechanical competence10.1038/s41413-022-00219-8 ↗
2. NIH Consensus (2001). Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis Prevention, Diagnosis, and Therapy. J. Am. Med. Assoc., 285, 785–795.10.1001/jama.285.6.785 ↗
3. Melatonin: A potential agent in delaying leaf senescence10.1080/07352689.2020.1865637 ↗
4. Ferlazzo, N., Andolina, G., Cannata, A., Costanzo, M.G., Rizzo, V., Currò, M., Ientile, R., and Caccamo, D. (2020). Is Melatonin the Cornucopia of the 21st Century?. Antioxidants, 9.10.3390/antiox9111088 ↗
5. Hormones and oxidative stress: An overview10.1080/10715762.2019.1702656 ↗
6. Bone versus immune system10.1038/35046196 ↗
7. Interactions between immune and bone cells: New insights with many remaining questions10.1172/JCI11089 ↗
8. Cytokine imbalance in non-immunological chronic disease10.1006/cyto.2002.0882 ↗
9. Increased osteoclast development after estrogen loss: Mediation by interleukin-610.1126/science.1621100 ↗
10. Melatonin enhances vertical bone augmentation in rat calvaria secluded spaces10.4317/medoral.20904 ↗
11. Melatonin Suppresses Estrogen Deficiency-Induced Osteoporosis and Promotes Osteoblastogenesis by Inactivating the NLRP3 Inflammasome10.1007/s00223-018-0428-y ↗
12. Melatonin has a stimulatory effect on osteoblasts by upregulating Col-I and OPN expression/secretion10.54589/aol.33/2/125 ↗
13. Daily melatonin administration improves osseointegration in pinealectomized rats10.1590/1678-7757-2017-0470 ↗
14. A novel calcium aluminate-melatonin scaffold enhances bone regeneration within a calvarial defect10.1111/j.1600-079X.2012.00989.x ↗
15. Influence of melatonin associated with the Bio-Gide® membrane on osteoblast activity: An in vitro Study10.54589/aol.35/2/90 ↗
16. Oral administration of melatonin contained in drinking water increased bone strength in naturally aged mice10.1016/j.acthis.2020.151596 ↗
17. Melatonin improves the osseointegration of hydroxyapatite-coated titanium implants in senile female rats10.1007/s00391-019-01640-1 ↗
18. Evaluation of Effects of Topical Melatonin Application on Osseointegration of Dental Implant: An Experimental Study10.1563/aaid-joi-D-16-00048 ↗
19. Clinical and Radiographic Evaluation of Immediate Loaded Dental Implants with Local Application of Melatonin: A Preliminary Randomized Controlled Clinical Trial10.1563/aaid-joi-D-14-00277 ↗
20. Purpura, S., Fernandes, G.V.O., Oliveira, F.P., and de Castro, F.C. (2022). Effects of Melatonin in the Non-Surgical Treatment of Periodontitis: A Systematic Review. Appl. Sci., 12.10.3390/app122211698 ↗
21. Melatonin-micronutrients Osteopenia Treatment Study (MOTS): A translational study assessing melatonin, strontium (citrate), vitamin D3 and vitamin K2 (MK7) on bone density, bone marker turnover and health related quality of life in postmenopausal osteopenic women following a one-year double-blind RCT and on osteoblast-osteoclast co-cultures10.18632/aging.101158 ↗
22. Melatonin enhances hydrogen peroxide-induced apoptosis in human dental pulp cells10.1016/j.jds.2019.05.003 ↗
23. Kim, H.J., Kim, H.J., Bae, M.-K., and Kim, Y.-D. (2017). Suppression of Osteoclastogenesis by Melatonin: A Melatonin Receptor-Independent Action. Int. J. Mol. Sci., 18.10.3390/ijms18061142 ↗
24. du Sert, N.P., Hurst, V., Ahluwalia, A., Alam, S., Avey, M.T., Baker, M., Browne, W.J., Clark, A., Cuthill, I.C., and Dirnagl, U. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. PLOS Biol., 18.10.1371/journal.pbio.3000410 ↗
25. (2016). Biological Evaluation of Medical Devices—Part 6: Tests for Local Effects after Implantation (Standard No. ISO 10993-6:2016).
26. Critical-size defects reconstruction with four different bone grafts associated with e-PTFE membrane: A histomorphometric experimental in vivo study10.1111/clr.14210 ↗
27. Histomorfometria do tecido ósseo em ratas castradas tratadas com tibolona10.1590/S1676-24442010000300010 ↗
28. Rebelo, C.G., Fernandes, J.C.H., Bernardo, N., Couto, P., and Fernandes, G.V.O. (2023). Bisphosphonates and Their Influence on the Implant Failure: A Systematic Review. Appl. Sci., 13.10.3390/app13063496 ↗
29. Bio-inspired Janus microcarriers with sequential actives release for bone regeneration10.1016/j.cej.2023.146797 ↗
30. Sustained Release of Melatonin from GelMA Liposomes Reduced Osteoblast Apoptosis and Improved Implant Osseointegration in Osteoporosis10.1155/2020/6797154 ↗
31. Osteoporosis: A Review of Treatment Options
32. Melatonin: Another avenue for treating osteoporosis?10.1111/jpi.12548 ↗
33. Melatonin Is Involved in Citrus Response to the Pathogen Huanglongbing via Modulation of Phytohormonal Biosynthesis10.1104/pp.20.00393 ↗
34. Melatonin expression in periodontitis and obesity: An experimental in-vivo investigation10.1111/jre.12571 ↗
35. Effects of local melatonin application on post-extraction sockets after third molar surgery. A pilot study
36. Evaluation of Immediate Implants Augmented with Autogenous Bone/Melatonin Composite Graft in the Esthetic Zone: A Randomized Controlled Trial10.1111/jopr.12631 ↗
37. Ovariectomized rat model of osteoporosis: A practical guide
38. Comparison between two experimental protocols to promote osteoporosis in the maxilla and proximal tibia of female rats10.1590/S1517-74912003000400002 ↗
39. Estrogen and alendronate therapies may prevent the influence of estrogen deficiency on the tooth-supporting alveolar bone: A histometric study in rats10.1111/j.1600-0765.2006.00903.x ↗
40. Constructive effect of exogenous melatonin against osteoporosis after ovariectomy in rats
41. Strength training reverses ovariectomy-induced bone loss and improve metabolic parameters in female Wistar rats10.1016/j.lfs.2018.10.032 ↗
42. Melatonin ameliorates SGLT2 inhibitor-induced diabetic ketoacidosis by inhibiting lipolysis and hepatic ketogenesis in type 2 diabetic mice10.1111/jpi.12623 ↗
43. Effect of Melatonin Supplementation on Antioxidant Status and DNA Damage in High Intensity Trained Athletes10.1055/s-0043-119881 ↗
44. Vieira, A.E., Repeke, C.E., Junior, S.B.F., Colavite, P.M., Biguetti, C.C., Oliveira, R.C., Assis, G.F., Taga, R., Trombone, A.P.F., and Garlet, G.P. (2015). Intramembranous Bone Healing Process Subsequent to Tooth Extraction in Mice: Micro-Computed Tomography, Histomorphometric and Molecular Characterization. PLoS ONE, 10.10.1371/journal.pone.0128021 ↗
45. Bonato, R.S., Fernandes, G.V.O., Calasans-Maia, M.D., Mello, A., Rossi, A.M., Carreira, A.C.O., Sogayar, M.C., and Granjeiro, J.M. (2022). The Influence of rhBMP-7 Associated with Nanometric Hydroxyapatite Coatings Titanium Implant on the Osseointegration: A Pre-Clinical Study. Polymers, 14.10.3390/polym14194030 ↗
46. Effects on bone by the light/dark cycle and chronic treatment with melatonin and/or hormone replacement therapy in intact female mice10.1111/j.1600-079X.2012.01007.x ↗